Naoyoshi Onoda
- Oncology top 1%
- Cancer Treatment and Pharmacology 21
- Cancer-related Molecular Pathways 16
- HER2/EGFR in Cancer Research 16
-
- Thyroid Cancer Diagnosis and Treatment 47
- Cancer Research top 2%
- Breast Cancer Treatment Studies 24
-
- Breast Lesions and Carcinomas 19
- Nephrology top 5%
-
- Gastric Cancer Management and Outcomes 21
-
- Thyroid and Parathyroid Surgery 18
- Co-authors
- Kosei HirakawaKiyoshi MaedaTsutomu TakashimaShinichiro KashiwagiYasuyuki KatoMichio SowaSatoru NodaTetsuro Ishikawa
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)Gastroenterology (1 paper)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Naoyoshi Onoda
215 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 1.8k
- Endocrinology, Diabetes and Metabolism 1.1k
- Cancer Research 866
- Pathology and Forensic Medicine 554
- Nephrology 205
Countries citing papers authored by Naoyoshi Onoda
This map shows the geographic impact of Naoyoshi Onoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoyoshi Onoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoyoshi Onoda more than expected).
Fields of papers citing papers by Naoyoshi Onoda
This network shows the impact of papers produced by Naoyoshi Onoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoyoshi Onoda. The network helps show where Naoyoshi Onoda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naoyoshi Onoda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2022 | 32 | |
| 8 | 2020 | 27 | |
| 9 | 2019 | 130 | |
| 10 | 2019 | 20 | |
| 11 | Factors Influencing the Chemo-Sensitivity of Weekly Paclitaxel for Anaplastic Thyroid Cancer: A Clinico-Pathologic Analysis of Cases Enrolled in a Clinical Trial | 2019 | 1 |
| 12 | [A Case of Male Breast Cancer Suspected of Breast Metastasis from Pancreatic Cancer]. | 2018 | 2 |
| 13 | 2016 | 92 | |
| 14 | [Effectiveness of eribulin chemotherapy for squamous cell carcinoma of the breast]. | 2013 | 6 |
| 15 | [Our experience of eribulin treatment in advanced breast cancer]. | 2013 | 1 |
| 16 | 2006 | 14 | |
| 17 | 1997 | 10 | |
| 18 | 1997 | 123 | |
| 19 | [Eumycotic mycetoma of the lower leg]. | 1997 | 2 |
| 20 | [Nuclear DNA ploidy pattern and proliferating cell nuclear antigen labeling index in gastric cancer with mucosal involvement]. | 1994 | 1 |
About Naoyoshi Onoda
Naoyoshi Onoda is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Oncology, having authored 236 papers that have together received 4.3k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (47 papers), Breast Cancer Treatment Studies (24 papers), Gastric Cancer Management and Outcomes (21 papers), Cancer Treatment and Pharmacology (21 papers), Breast Lesions and Carcinomas (19 papers), Thyroid and Parathyroid Surgery (18 papers), Cancer-related Molecular Pathways (16 papers) and HER2/EGFR in Cancer Research (16 papers). The work is most often cited by research in Oncology (1.8k citations), Endocrinology, Diabetes and Metabolism (1.1k citations) and Cancer Research (866 citations). Naoyoshi Onoda has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Kosei Hirakawa, Kiyoshi Maeda, Tsutomu Takashima, Shinichiro Kashiwagi, Yasuyuki Kato, Michio Sowa, Satoru Noda, Tetsuro Ishikawa, Yasuhiro Ito and Yuka Asano. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.